RelayPro Thoracic Stent-Graft Delivery System
Bolton Medical, Inc. · Decision date Oct 28, 2026
What did the FDA decide?
FDA recorded a 30-Day Notice decision coded OK30 on 2026-10-28 for supplement P200045/S025 to PMA P200045, submitted by Bolton Medical, Inc. for the RelayPro Thoracic Stent-Graft Delivery System. The supplement type is listed as a 30-Day Notice with the reason Process Change - Manufacturer/Sterilizer/Packager/Supplier, and the recorded statement describes combining two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System.
The record covers a manufacturing process change to the delivery system rather than a new approval of the full stent-graft system, and the source does not describe the affected components, the sterilization or packaging sites involved, or any conditions attached to the decision. The device category is listed as SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT, with Cardiovascular specialty and product code MIH. No supporting documents were included, so the basis for OK30 and any clinical implications remain unknown from this record.
FDA approval order statement
combination of two delivery system components into a single component for the RelayPro Thoracic Stent-Graft System
- Regulatory pathway
- PMA supplement
- Supplement type
- 30-Day Notice
- Clinical specialty
- Cardiovascular
- Decision date
- Oct 28, 2026
- FDA change category
- Process Change - Manufacturer/Sterilizer/Packager/Supplier
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- P200045/S025
- Regulatory pathway
- PMA supplement
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- Decision code
- OK30
- Decision date
- Oct 28, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: SYSTEM, ENDOVASCULAR GRAFT, AORTIC ANEURYSM TREATMENT.
- Applicant
- Bolton Medical, Inc.
- Product code
- MIH
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200045. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200045 · Original PMA
RelayPro Thoracic Stent-Graft System
P200045/S025 received
Application receipt date recorded by FDA.
P200045/S025 · FDA decision
30-Day Notice
Timeline entries are records held by MedtechLedger for P200045. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200045
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Bolton Medical, Inc. | PMA approval | Aug 5, 2021 | FDA |
Explore the linked device profile
Other records with product code MIH
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| Cook, Inc. | PMA supplement | Sep 17, 2026 | FDA | |
| Cook, Inc. | PMA approval | May 23, 2003 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Bolton Medical, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- 799 International Pkwy., Sunrise, FL, 33325
Sources and methodology
- Original FDA record: P200045/S025
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records

